Srinivas Akkaraju

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Srinivas Akkaraju
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Srinivas Akkaraju:

Company Role Class Num Shares Value Price $ Report Date Ownership
Mineralys Therapeutics, Inc. Director Common Stock 5,674,916 $86,372,221 $15.22 04 Sep 2025 By Samsara BioCapital, L.P.
Kalaris Therapeutics, Inc. Director, 10%+ Owner Common Stock 11,448,081 $58,041,770 $5.07 22 Dec 2025 By Samsara BioCapital, L.P.
Scholar Rock Holding Corp Director Common Stock 6,367,614 $46,801,962 $7.35 12 Dec 2025 By Samsara BioCapital, L.P.
ALUMIS INC. Director Common Stock 4,491,731 $43,839,743 $9.76 09 Jan 2026 By Samsara BioCapital, L.P.
ALUMIS INC. Director Common Stock 1,853,488 $31,509,296 $17.00 09 Jan 2026 By Samsara Opportunity Fund, L.P.
vTv Therapeutics Inc. Director Pre-Funded Warrants (Right to Buy) 1,548,101 $23,221,515 $15.00 22 Sep 2025 By Samsara BioCapital, L.P.
Scholar Rock Holding Corp Director Common Stock 530,038 $21,715,656 $40.97 07 Oct 2025 By Samsara Opportunity Fund, L.P.
Kalaris Therapeutics, Inc. Director, 10%+ Owner Common Stock 1,500,000 $15,000,000 $10.00 22 Dec 2025 By Samsara Opportunity Fund, L.P.
Mineralys Therapeutics, Inc. Director Common Stock 588,235 $14,999,992 $25.50 04 Sep 2025 By Samsara Opportunity Fund, L.P.
vTv Therapeutics Inc. Director Warrant (Right to Buy) 983,214 $14,748,210 $15.00 22 Sep 2025 By Samsara Opportunity Fund, L.P.
vTv Therapeutics Inc. Director Pre-Funded Warrants (Right to Buy) 877,214 $13,158,210 $15.00 22 Sep 2025 By Samsara Opportunity Fund, L.P.
vTv Therapeutics Inc. Director Pre-Funded Warrants (Right to Buy) 1,548,101 $10,532,420 $11.80 03 Sep 2025 Samsara BioCapital, L.P.
vTv Therapeutics Inc. Director Warrant (Right to Buy) 655,523 $9,832,845 $15.00 22 Sep 2025 By Samsara BioCapital, L.P
vTv Therapeutics Inc. Director Class A Common Stock 206,784 $3,101,760 $15.00 22 Sep 2025 By Samsara BioCapital, L.P.
vTv Therapeutics Inc. Director Class A Common Stock 106,000 $1,618,090 $15.26 22 Sep 2025 By Samsara Opportunity Fund, L.P.
Scholar Rock Holding Corp Director Common Stock 21,132 $911,845 $43.15 07 Oct 2025 Direct
vTv Therapeutics Inc. Director Director stock option (right to buy) 10,983 $182,207 $16.59 10 Jun 2025 Direct
Syros Pharmaceuticals, Inc. Director Common Stock 9,333 $15,644 $1.68 16 Sep 2024 Direct
Syros Pharmaceuticals, Inc. Director Restricted Stock Units 2,667 $4,470 $1.68 16 Sep 2024 Direct
Jiya Acquisition Corp. Director, 10%+ Owner Class B Common Stock 2,437,114 23 Sep 2022 Indirect
vTv Therapeutics Inc. Director Warrant to Purchase Class A Common Stock (Right to Buy) 655,523 03 Sep 2025 By Samsara BioCapital, L.P.
ALUMIS INC. Director Stock Option (Right to Buy) 49,800 30 Jul 2025 Direct
Mineralys Therapeutics, Inc. Director Stock Option 32,900 13 Feb 2025 Direct
Kalaris Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 18,000 10 Apr 2025 Direct
Scholar Rock Holding Corp Director Stock Option (Right to Buy) 9,206 22 May 2025 Direct
Syros Pharmaceuticals, Inc. Director Stock Option (right to buy) 6,000 05 Jun 2024 Direct
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 11 Aug 2023 By Samsara BioCapital, L.P.
CHINOOK THERAPEUTICS, INC. Director Common Stock 0 $39.03 11 Aug 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Restricted Stock Units 0 26 May 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Stock Option (Right to Buy) 0 $26.12 11 Aug 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. Director Common Stock 0 $19.00 08 Nov 2023 Indirect
INTERCEPT PHARMACEUTICALS, INC. Director Option to Purchase Common Stock 0 08 Nov 2023 Direct
Scholar Rock Holding Corp Director Warrants to Purchase Common Stock 0 12 Dec 2025 By Samsara BioCapital LP

Insider Reports Filed by Srinivas Akkaraju

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALMS ALUMIS INC. 09 Jan 2026 1 +$9,999,995 4 Director 13 Jan 2026, 18:20
KLRS Kalaris Therapeutics, Inc. 22 Dec 2025 1 +$15,000,000 4 Director, 10%+ Owner 22 Dec 2025, 16:15
ALMS ALUMIS INC. 05 Dec 2025 3 +$1,833,760 4 Director 09 Dec 2025, 19:13
ALMS ALUMIS INC. 02 Dec 2025 3 +$2,039,901 4 Director 04 Dec 2025, 20:11
ALMS ALUMIS INC. 26 Nov 2025 3 +$1,310,677 4 Director 01 Dec 2025, 18:09
ALMS ALUMIS INC. 20 Nov 2025 1 +$905,350 4 Director 24 Nov 2025, 18:50
ALMS ALUMIS INC. 17 Nov 2025 3 +$1,529,865 4 Director 19 Nov 2025, 20:46
ALMS ALUMIS INC. 13 Nov 2025 1 +$1,449,940 4 Director 17 Nov 2025, 16:59
SRRK Scholar Rock Holding Corp 07 Oct 2025 5 +$9,007,943 4 Director 16 Dec 2025, 21:07
SRRK Scholar Rock Holding Corp 03 Oct 2025 6 +$18,807,352 4 Director 07 Oct 2025, 20:59
VTVT vTv Therapeutics Inc. 22 Sep 2025 3 +$1,618,090 4 Director 25 Sep 2025, 17:04
MLYS Mineralys Therapeutics, Inc. 04 Sep 2025 1 +$14,999,992 4 Director 08 Sep 2025, 20:07
VTVT vTv Therapeutics Inc. 03 Sep 2025 2 $0 4 Director 05 Sep 2025, 18:10
ALMS ALUMIS INC. 30 Jul 2025 1 $0 4 Director 01 Aug 2025, 16:05
VTVT vTv Therapeutics Inc. 10 Jun 2025 1 +$66,360 4 Director 12 Jun 2025, 16:27
SRRK Scholar Rock Holding Corp 22 May 2025 2 $0 4 Director 23 May 2025, 16:44
ALMS ALUMIS INC. 21 May 2025 1 $0 4 Director 23 May 2025, 20:47
ALMS ALUMIS INC. 02 May 2025 3 +$1,477,312 4 Director 06 May 2025, 18:52
KLRS Kalaris Therapeutics, Inc. 10 Apr 2025 1 $0 4 Director, 10%+ Owner 11 Apr 2025, 17:20
KLRS Kalaris Therapeutics, Inc. 18 Mar 2025 0 $0 3/A Director, 10%+ Owner 26 Mar 2025, 17:06
KLRS Kalaris Therapeutics, Inc. 18 Mar 2025 1 $0 4 Director, 10%+ Owner 18 Mar 2025, 17:40
MLYS Mineralys Therapeutics, Inc. 13 Mar 2025 1 +$8,100,000 4 Director 17 Mar 2025, 21:04
MLYS Mineralys Therapeutics, Inc. 13 Feb 2025 1 $0 4 Director, 10%+ Owner 24 Feb 2025, 18:59
SRRK Scholar Rock Holding Corp 07 Oct 2024 3 -$34,385,672 4 Director 07 Oct 2024, 20:55
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2024 2 $0 4 Director 18 Sep 2024, 17:00
ALMS ALUMIS INC. 01 Jul 2024 1 +$25,000,000 4/A Director 27 Aug 2024, 16:10
SRRK Scholar Rock Holding Corp 27 Jun 2024 2 $0 4 Director 01 Jul 2024, 17:13
ALMS ALUMIS INC. 27 Jun 2024 0 $0 3 Director 27 Jun 2024, 16:09
VTVT vTv Therapeutics Inc. 25 Jun 2024 2 +$55,672 4 Director 24 Apr 2025, 16:40
SYRS Syros Pharmaceuticals, Inc. 05 Jun 2024 2 $0 4 Director 07 Jun 2024, 16:30
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2024 2 $0 4 Director 04 Jun 2024, 16:41
MLYS Mineralys Therapeutics, Inc. 22 May 2024 1 $0 4 Director, 10%+ Owner 23 May 2024, 16:21
VTVT vTv Therapeutics Inc. 05 Mar 2024 2 $0 4 Director, 10%+ Owner 06 Dec 2024, 16:15
VTVT vTv Therapeutics Inc. 27 Feb 2024 1 $0 4 Director, 10%+ Owner 13 Jun 2024, 18:22
VTVT vTv Therapeutics Inc. 27 Feb 2024 2 +$12,491,662 4 Director, 10%+ Owner 29 Feb 2024, 19:33
VTVT vTv Therapeutics Inc. 23 Feb 2024 0 $0 3 Director, 10%+ Owner 29 Feb 2024, 19:31
MLYS Mineralys Therapeutics, Inc. 12 Feb 2024 1 +$7,499,992 4 Director, 10%+ Owner 14 Feb 2024, 21:07
SYRS Syros Pharmaceuticals, Inc. 21 Dec 2023 1 +$3,999,998 4 Director 26 Dec 2023, 17:24
/report/000110465923117119-akkaraju-srinivas-2023-11-08 INTERCEPT PHARMACEUTICALS, INC. 08 Nov 2023 13 -$13,047,034 4 Director 13 Nov 2023, 14:51
SRRK Scholar Rock Holding Corp 16 Oct 2023 1 +$15,000,000 4 Director, 10%+ Owner 18 Oct 2023, 17:46
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2023 2 $0 4 Director 19 Sep 2023, 17:46
/report/000120919123045411-akkaraju-srinivas-2023-08-11 CHINOOK THERAPEUTICS, INC. 11 Aug 2023 5 -$1,078,790 4 Director 11 Aug 2023, 16:04
SRRK Scholar Rock Holding Corp 21 Jun 2023 1 $0 4 Director 22 Jun 2023, 18:48
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2023 2 $0 4 Director 02 Jun 2023, 16:22
/report/000120919123033190-akkaraju-srinivas-2023-05-26 CHINOOK THERAPEUTICS, INC. 26 May 2023 2 $0 4 Director 31 May 2023, 19:25
/report/000110465923064838-akkaraju-srinivas-2023-05-24 INTERCEPT PHARMACEUTICALS, INC. 24 May 2023 2 $0 4 Director 25 May 2023, 20:37
MLYS Mineralys Therapeutics, Inc. 14 Feb 2023 4 +$15,000,000 4 Director, 10%+ Owner 16 Feb 2023, 15:54
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 1 $0 4 Director, 10%+ Owner 13 Feb 2023, 20:02
MLYS Mineralys Therapeutics, Inc. 09 Feb 2023 0 $0 3 Director, 10%+ Owner 09 Feb 2023, 18:52
/report/000095010322016364-akkaraju-srinivas-2022-09-23 Jiya Acquisition Corp. 23 Sep 2022 1 $0 4 Director, 10%+ Owner 23 Sep 2022, 18:39
SYRS Syros Pharmaceuticals, Inc. 16 Sep 2022 4 $0 4/A Director 20 Apr 2023, 16:39
SRRK Scholar Rock Holding Corp 16 Sep 2022 1 $0 4 Director 20 Sep 2022, 16:15
SRRK Scholar Rock Holding Corp 26 Jul 2022 0 $0 3 Director 28 Jul 2022, 17:02
SYRS Syros Pharmaceuticals, Inc. 01 Jun 2022 1 $0 4 Director 02 Jun 2022, 19:10
/report/000120919122033141-akkaraju-srinivas-2022-05-27 CHINOOK THERAPEUTICS, INC. 27 May 2022 1 +$7,980,000 4 Director 01 Jun 2022, 16:13
/report/000120919122032938-akkaraju-srinivas-2022-05-26 CHINOOK THERAPEUTICS, INC. 26 May 2022 2 $0 4 Director 31 May 2022, 18:04
/report/000110465922065916-akkaraju-srinivas-2022-05-25 INTERCEPT PHARMACEUTICALS, INC. 25 May 2022 2 $0 4 Director 27 May 2022, 16:18
/report/000120919121064987-akkaraju-srinivas-2021-11-15 CHINOOK THERAPEUTICS, INC. 15 Nov 2021 1 +$17,010,000 4 Director 17 Nov 2021, 11:05
/report/000095010321014674-akkaraju-srinivas-2021-09-23 Jiya Acquisition Corp. 23 Sep 2021 2 $0 4 Director, 10%+ Owner 27 Sep 2021, 16:52
/report/000095010321013192-akkaraju-srinivas-2021-08-26 Jiya Acquisition Corp. 26 Aug 2021 1 $0 4 Director, 10%+ Owner 30 Aug 2021, 16:04
/report/000120919121052814-akkaraju-srinivas-2021-08-18 CHINOOK THERAPEUTICS, INC. 18 Aug 2021 1 +$2,497,830 4 Director 20 Aug 2021, 17:37
SYRS Syros Pharmaceuticals, Inc. 08 Jun 2021 1 $0 4 Director 10 Jun 2021, 17:39
/report/000120919121039000-akkaraju-srinivas-2021-06-04 CHINOOK THERAPEUTICS, INC. 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 18:07
/report/000110465921075214-akkaraju-srinivas-2021-05-27 INTERCEPT PHARMACEUTICALS, INC. 27 May 2021 2 $0 4 Director 01 Jun 2021, 19:00